A study found that LncRNA DANCR could target FOXO1 and cause its low expression, further inhibiting the binding of FOXD3-AS1 to the promoter region of PID1 to decrease the expression of PID1 protein, thereby promoting the tolerance of GBM cells to temozolomide [94]. Here, FOXD3 is linked to glioblastoma.